A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models
系统性给药的去毒 TLR4 激动剂在临床前模型中表现出强大的抗肿瘤活性和可接受的耐受性
期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2023.1066402
Kamel Chettab, Chantel Fitzsimmons, Alexey Novikov, Morgane Denis, Capucine Phelip, Doriane Mathé, Pierre Antoine Choffour, Sabine Beaumel, Eric Fourmaux, Patrick Norca, David Kryza, Anne Evesque, Lars Petter Jordheim, Emeline Perrial, Eva-Laure Matera, Martine Caroff, Jerome Kerzerho, Charles Dumon
